Press Releases
Biosimilars & Biobetters USA – Industry leaders will meet in Iselin, New Jersey, in April 2014
Creating an Innovate Plan for the USA Biosimilars Market: presentations from Sandoz, IMS Health, Bristows, PRA International, Celltrion, MedImmune, Novartis, Lonza Biologics and others. After the phenomenal success of our Biosimilars and Biobetters event hosted in...
Press Releases
Eureka Science proudly announces the collaboration with international societies & organizations for their events “6th International Conference on Drug Discovery” and “Therapy and 3rd...
Eureka Science proudly announces the collaboration with international societies and organizations for the events; the “6th International Conference on Drug Discovery and Therapy” and the “3rd Biotechnology World Congress” to be held in Dubai, UAE, from February 10th -...
Press Releases
FibroGen Announces Analysis of Peritoneal Dialysis Patients With Chronic Kidney Disease From Roxadustat (FG-4592) Incident Dialysis Study
FibroGen Inc. (FibroGen) today announced the presentation of a Phase 2 subgroup analysis comparing treatment response to roxadustat (FG-4592) a first-in-class oral compound in late stage development in incident peritoneal dialysis (PD) patients and incident hemodialysis (HD) patients for...
Press Releases
Oncodesign and UCB enter into a research collaboration for the early development of new therapeutic agents in neurodegenerative diseases
The partnership is based on Oncodesign's Nanocyclix(R) technology platform for next generation kinase inhibitors and UCB’s expertise in neurology. Oncodesign, a drug discovery company and oncology pharmacology service provider, announces today that it has entered...
Press Releases
Adocia announces the initiation of a clinical trial on its combination of the long-acting insulin Glargine and a fast-acting insulin analog
This phase I/II clinical trial on Type I Diabetics seeks to compare the performance of this Combo based on insulin Glargine with HumalogMix(R). Adocia , a biotechnology company specializing in the development of ‘best-in-class’ medicines...
Press Releases
Avedro Announces the Start of Two New US FDA Trials for Accelerated Cross-linking
Avedro Inc. a Boston-based ophthalmic medical device and pharmaceutical company announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking. Lasik with cross-linking...
Press Releases
Advanced research instrumentation pioneer Oxford Optronix launches HypoxyLab™ – the industry’s first benchtop, HEPA-filtered hypoxia workstation
Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces the formal launch of HypoxyLab™ – the industry’s first benchtop, HEPA-filtered, precision-controlled hypoxia workstation. HypoxyLab creates...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.